Aralez Pharmaceuticals Inc. 4
4 · Aralez Pharmaceuticals Inc. · Filed Mar 22, 2017
Insider Transaction Report
Form 4
Charles Scott J
Chief Financial Officer
Transactions
- Sale
Common Shares, without par value
2017-03-20$2.41/sh−5,205$12,544→ 208,163 total
Footnotes (1)
- [F1]This represents shares sold by the issuer on behalf of the reporting person pursuant to an instruction made in accordance with Rule 10b5-1 for payment of withholding tax liability incurred upon the vesting of 15,789 restricted stock units, which were previously granted on March 17, 2016 and which vested on March 17, 2017.